Global RNA-based Biopharmaceuticals Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
- Published Date: 2021-04-23
- Report ID: 106082
- Pages: 117
-
Format:
Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
Prudent Markets analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global RNA-based Biopharmaceuticals market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of RNA-based Biopharmaceuticals Market by Prudent Markets Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in RNA-based Biopharmaceuticals Market
Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals
...
Major Type of RNA-based Biopharmaceuticals Covered in Prudent Markets report:
Therapeutics
Vaccines
Application Segments Covered in Prudent Markets Market
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global RNA-based Biopharmaceuticals Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Therapeutics -Product Introduction and Major Manufacturers
1.1.2 Vaccines -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China RNA-based Biopharmaceuticals Status and Prospect (2015-2026)
2.1.1 China RNA-based Biopharmaceuticals Market Size and Growth Rate (2015-2026)
2.1.2 China RNA-based Biopharmaceuticals Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU RNA-based Biopharmaceuticals Status and Prospect (2015-2026)
2.2.1 EU RNA-based Biopharmaceuticals Market Size and Growth Rate (2015-2026)
2.2.2 EU RNA-based Biopharmaceuticals Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA RNA-based Biopharmaceuticals Status and Prospect (2015-2026)
2.3.1 USA RNA-based Biopharmaceuticals Market Size and Growth Rate (2015-2026)
2.3.2 USA RNA-based Biopharmaceuticals Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan RNA-based Biopharmaceuticals Status and Prospect (2015-2026)
2.4.1 Japan RNA-based Biopharmaceuticals Market Size and Growth Rate (2015-2026)
2.4.2 Japan RNA-based Biopharmaceuticals Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India RNA-based Biopharmaceuticals Status and Prospect (2015-2026)
2.5.1 India RNA-based Biopharmaceuticals Market Size and Growth Rate (2015-2026)
2.5.2 India RNA-based Biopharmaceuticals Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia RNA-based Biopharmaceuticals Status and Prospect (2015-2026)
2.6.1 Southeast Asia RNA-based Biopharmaceuticals Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia RNA-based Biopharmaceuticals Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America RNA-based Biopharmaceuticals Status and Prospect (2015-2026)
2.7.1 South America RNA-based Biopharmaceuticals Market Size and Growth Rate (2015-2026)
2.7.2 South America RNA-based Biopharmaceuticals Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 RNA-based Biopharmaceuticals Status and Prospect (2015-2026)
2.8.1 RNA-based Biopharmaceuticals Market Size and Growth Rate (2015-2026)
2.8.2 RNA-based Biopharmaceuticals Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global RNA-based Biopharmaceuticals Market Assessment by Segment
3.1 Global RNA-based Biopharmaceuticals Capacity and Growth Rate
3.2 Global RNA-based Biopharmaceuticals Sales by Type
3.3 Global RNA-based Biopharmaceuticals Sales Revenue by Type
3.4 Global RNA-based Biopharmaceuticals Consumption by Application
4 Global RNA-based Biopharmaceuticals Market Assessment by Regions
4.1 Global RNA-based Biopharmaceuticals Production Analysis and Forecast by Regions (2015-2026)
4.2 Global RNA-based Biopharmaceuticals Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global RNA-based Biopharmaceuticals Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 RNA-based Biopharmaceuticals Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on RNA-based Biopharmaceuticals Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global RNA-based Biopharmaceuticals Capacity Market Share of Manufacturers (2019-2020)
6.2 Global RNA-based Biopharmaceuticals Sales Market Share of Manufacturers (2019-2020)
6.3 Global RNA-based Biopharmaceuticals Sales Revenue Market Share of Manufacturers (2019-2020)
7 RNA-based Biopharmaceuticals Competitive Analysis
7.1 Pfizer
7.1.1 Pfizer Company Profiles
7.1.2 Pfizer Product Introduction
7.1.3 Pfizer RNA-based Biopharmaceuticals Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Roche
7.2.1 Roche Company Profiles
7.2.2 Roche Product Introduction
7.2.3 Roche RNA-based Biopharmaceuticals Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Sanofi-Aventis
7.3.1 Sanofi-Aventis Company Profiles
7.3.2 Sanofi-Aventis Product Introduction
7.3.3 Sanofi-Aventis RNA-based Biopharmaceuticals Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Company Profiles
7.4.2 Abbott Laboratories Product Introduction
7.4.3 Abbott Laboratories RNA-based Biopharmaceuticals Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Arrowhead Pharmaceuticals
7.5.1 Arrowhead Pharmaceuticals Company Profiles
7.5.2 Arrowhead Pharmaceuticals Product Introduction
7.5.3 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Benitec Biopharma
7.6.1 Benitec Biopharma Company Profiles
7.6.2 Benitec Biopharma Product Introduction
7.6.3 Benitec Biopharma RNA-based Biopharmaceuticals Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Calimmune Inc
7.7.1 Calimmune Inc Company Profiles
7.7.2 Calimmune Inc Product Introduction
7.7.3 Calimmune Inc RNA-based Biopharmaceuticals Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Dicerna
7.8.1 Dicerna Company Profiles
7.8.2 Dicerna Product Introduction
7.8.3 Dicerna RNA-based Biopharmaceuticals Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Gradalis
7.9.1 Gradalis Company Profiles
7.9.2 Gradalis Product Introduction
7.9.3 Gradalis RNA-based Biopharmaceuticals Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Quark
7.10.1 Quark Company Profiles
7.10.2 Quark Product Introduction
7.10.3 Quark RNA-based Biopharmaceuticals Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 RXi
7.12 Senesco
7.13 Silence Therapeutics
7.14 Silenseed
7.15 Tekmira
7.16 Alnylam Pharmaceuticals
8 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
